INS and type 2 diabetes mellitus: We used publicly available results from GWAS in various consortia to investigate whether rs944990 or rs10821128 was associated with any other growth-related endpoint (including BMI, height, waist to hip ratio, obesity, glucose, insulin, homeostatic model assessment–insulin resistance (HOMA-IR) and type 2 diabetes in adults, age of menarche, pubertal growth and obesity in children and birthweight, birth length and head circumference at birth).